Disproportionality analysis of adverse events associated with tyrosine kinase inhibitors in gastrointestinal stromal tumors in the FDA adverse event reporting system

Naunyn-Schmiedeberg s Archives of Pharmacology 2026

View at publisher

Authors: Yibin Teng, Henan Qin, Ying Lin, Aman Wang, Jiwei Liu

DOI: 10.1007/s00210-026-05767-y

Cited by: 1

References: 32

Fields of Study & Subjects

Gastrointestinal Tumor Research and Treatment Gastric Cancer Management and Outcomes Gastrointestinal Bleeding Diagnosis and Treatment

References 32